Burden of aspergillosis-related hospitalizations in the United States
Burden of aspergillosis-related hospitalizations in the United States
复制标题
DOI：
10.1086/317487
复制
发表时间：
2000-12-01
影响因子：
11.8
通讯作者：
Teutsch, SM
中科院分区：
文献类型：
--
作者：
Dasbach, EJ;Davies, GM;Teutsch, SM
1996年，在美国，估计有10,190人因曲霉病住院(95%可信区间，9,000-11,380)；这些结果导致1970年死亡(95%可信区间，1,659-2,280)，176,272天住院(95%可信区间，147,163-206,275)，以及6.331亿美元的费用(95%可信区间，492.0-7.802亿美元)。平均住院时间为17.3天(95%可信区间，16.1-18.6)，平均住院费用为62426美元(95%可信区间，52670-72181美元)。尽管与曲霉病相关的住院治疗只占美国住院患者的一小部分，但这种情况下住院的患者住院时间长，死亡率高。
In the United States in 1996, there were an estimated 10,190 aspergillosis-related hospitalizations (95% confidence interval [CI], 9000-11,380); these resulted in 1970 deaths (95% CI, 1659-2280), 176,272 hospital days (95% CI, 147,163-206,275), and $633.1 million in costs (95% CI, $492.0-$780.2 million). The average hospitalization lasted 17.3 days (95% CI, 16.1-18.6) and cost $62,426 (95% CI, $52,670-$72,181). Although aspergillosis-related hospitalizations account for a small percentage of hospitalizations in the United States, patients hospitalized with the condition have lengthy hospital stays and high mortality rates.